↓ Skip to main content

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

Overview of attention for article published in BMC Cancer, November 2011
Altmetric Badge

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
59 Mendeley